HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shin Yomogida Selected Research

B-Cell Leukemia (Leukemia, B Cell)

10/2013Cytotoxic effects of caffeic acid undecyl ester are involved in the inhibition of telomerase activity in NALM-6 human B-cell leukemia cells.
2/2013Induction of apoptosis by a potent caffeic acid derivative, caffeic acid undecyl ester, is mediated by mitochondrial damage in NALM-6 human B cell leukemia cells.
9/2012Characterization of cells resistant to the potent histone deacetylase inhibitor spiruchostatin B (SP-B) and effect of overexpressed p21waf1/cip1 on the SP-B resistance or susceptibility of human leukemia cells.
5/2012Involvement of p21waf1/cip1 expression in the cytotoxicity of the potent histone deacetylase inhibitor spiruchostatin B towards susceptible NALM-6 human B cell leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shin Yomogida Research Topics

Disease

4Neoplasms (Cancer)
08/2014 - 01/2012
4B-Cell Leukemia (Leukemia, B Cell)
10/2013 - 05/2012
3Hepatocellular Carcinoma (Hepatoma)
01/2015 - 02/2011
2Breast Neoplasms (Breast Cancer)
08/2014 - 11/2013
2Leukemia
09/2012 - 05/2012
2Osteoarthritis
03/2010 - 09/2008
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2008 - 08/2008
1Chemical and Drug Induced Liver Injury
01/2016
1Prostatic Neoplasms (Prostate Cancer)
01/2013
1T-Cell Leukemia (Leukemia, T Cell)
01/2012
1Carcinogenesis
02/2011
1Mycoses (Diseases, Fungus)
04/2009
1Septic Shock (Toxic Shock Syndrome)
03/2009
1Inflammation (Inflammations)
09/2008
1Colitis
09/2008

Drug/Important Bio-Agent (IBA)

2Docosahexaenoic AcidsIBA
01/2015 - 02/2011
2papuamineIBA
08/2014 - 11/2013
2caffeic acid undecyl esterIBA
10/2013 - 02/2013
2AlbuminsIBA
01/2013 - 02/2011
2spiruchostatin BIBA
09/2012 - 05/2012
2Histone Deacetylase InhibitorsIBA
09/2012 - 05/2012
2Histone Deacetylases (Histone Deacetylase)IBA
09/2012 - 05/2012
2Glucosamine (Dona)IBA
03/2010 - 09/2008
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2016
1pifithrinIBA
01/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2014
1JNK Mitogen-Activated Protein KinasesIBA
08/2014
1Telomerase (Telomerase Reverse Transcriptase)IBA
10/2013
1caffeic acid phenethyl esterIBA
02/2013
1caffeic acidIBA
02/2013
1AndrogensIBA
01/2013
1Sorafenib (BAY 43-9006)FDA Link
01/2013
1Warfarin (Coumadin)FDA LinkGeneric
01/2013
1Messenger RNA (mRNA)IBA
05/2012
1acacetinIBA
01/2012
1AntioxidantsIBA
01/2012
1FlavonoidsIBA
01/2012
1CaspasesIBA
01/2012
1Fish OilsIBA
02/2011
1Small Interfering RNA (siRNA)IBA
02/2011
1AcidsIBA
02/2011
1Collagen Type II (Type II Collagen)IBA
03/2010
1Proteoglycans (Proteoglycan)IBA
03/2010
1Tolonium ChlorideFDA Link
03/2010
1Biomarkers (Surrogate Marker)IBA
03/2010
1Peptides (Polypeptides)IBA
04/2009
1LipopolysaccharidesIBA
03/2009
1EndotoxinsIBA
03/2009
1HMGB1 Protein (HMG1)IBA
03/2009
1Dextran SulfateIBA
09/2008
1MonosaccharidesIBA
09/2008
1NF-kappa B (NF-kB)IBA
09/2008
1Interleukin-8 (Interleukin 8)IBA
08/2008
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2008
1ChemokinesIBA
08/2008

Therapy/Procedure

2Drug Therapy (Chemotherapy)
08/2014 - 05/2012